Európska únia - slovenčina - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - hepatitis a virus (inactivated), hepatitis b surface antigen - immunization; hepatitis b; hepatitis a - vakcíny - twinrix paediatric je indikovaný na použitie u neimunitných dojčiat, detí a adolescentov vo veku od jedného roka do 15 rokov vrátane, u ktorých je riziko infekcie hepatitídy a a hepatitídy b.

Európska únia - slovenčina - EMA (European Medicines Agency)

ceva santé animale - influenza a virus/human strain: a/jena/vi5258/2009 (h1n1)pdm09, inactivated - imunologické lieky, inaktivované vírusové vakcíny pre ošípané, vírus ošípaných - ošípané - aktívna imunizácia ošípaných vo veku od 8 týždňov proti pandemickému vírusu chrípky ošípaných h1n1 na zníženie zaťaženia vírusu pľúc a vírusovej exkrécie. the vaccine can be used during pregnancy up to three weeks before expected farrowing and during lactation lactation.

Európska únia - slovenčina - EMA (European Medicines Agency)

zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - imunologické prístroje pre sviňovité - ošípané (pre výkrm) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection.  onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination.  duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination.  in addition, vaccination has been shown to reduce body weight gain losses under field conditions.

Európska únia - slovenčina - EMA (European Medicines Agency)

seqirus s.r.l.  - zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted), influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/turkey/turkey/1/05 (h5n1)-like strain (nibrg-23) - influenza a virus, h5n1 subtype - vakcíny - active immunisation against h5 subtype of influenza a virus.

Európska únia - slovenčina - EMA (European Medicines Agency)

ceva santé animale - inaktivovaná vakcína proti coxiella burnetii, kmeň nine mile - immunologicals for bovidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - goats; cattle - cattle: , for the active immunisation of cattle to lower the risk for non-infected animals vaccinated when non-pregnant to become shedder (5 times lower probability in comparison with animals receiving a placebo), and to reduce shedding of coxiella burnetii in these animals via milk and vaginal mucus. , onset of immunity: not established. , duration of immunity: 280 days after completion of the primary vaccination course. , goats: , for the active immunisation of goats to reduce abortion caused by coxiella burnetii and to reduce shedding of the organism via milk, vaginal mucus, faeces and placenta. , onset of immunity: not established. , duration of immunity: one year after completion of the primary vaccination course.

Európska únia - slovenčina - EMA (European Medicines Agency)

laboratorios hipra, s.a. - rekombinantný verotoxín 2e z e. coli - inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium, immunologicals for suidae - ošípané - aktívna imunizácia prasiatok od veku 2 dní, aby sa zabránilo úmrtnosti a znížili sa klinické príznaky ochorenia edému (spôsobené verotoxínom 2e produkovaným e. coli) a na zníženie straty denného prírastku hmotnosti počas obdobia ukončenia tváre proti infekciám s verotoxínom 2e produkujúcim e. coli až do zabitia od veku 164 dní.

Slovensko - slovenčina - Ústav štátnej kontroly veterinárnych biopreparátov a liečiv

bioveta, Česká republilka - inj.

Európska únia - slovenčina - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - e. coli adhesin f4 (f4ab, f4ac, f4ad), e. coli adhesin f5, e. coli adhesin f6, e. coli adhesin f41 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - sows; sows (nullipar) - zníženie neonatálnej enterotoxikózy prasiatok spôsobené e. coli kmeňov, ktoré exprimujú adhezíny f4ab, f4ac, f4ad, f5, f6 a f41 počas prvých dní života.

Európska únia - slovenčina - EMA (European Medicines Agency)

intervet international bv - babesia canis, inactivated, babesia rossi, inactivated - imunologické vyšetrenie pre kanáriky - psy - pre aktívnej imunizácie psov šiestich mesiacov veku alebo starší proti babesia canis na zníženie závažnosti klinických príznakov spojených s akútnym babesiosis b. canis) a anémia meraná objemom buniek. nástup imunity: tri týždne po základnom očkovaní. trvanie imunity: šesť mesiacov po poslednej (opätovnej) vakcinácii.

Európska únia - slovenčina - EMA (European Medicines Agency)

intervet international b.v. - prasačí cirkovírus typu 2 antigén podjednotky orf2 - immunologicals for suidae, inactivated viral vaccines - ošípané - for the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues and virus shedding caused by pcv2 infection.  to reduce loss of daily weight gain and mortality associated with pcv2 infection.